# Observational Study of the Durability of Seroconversion Chronic HBV Patients Who Seroconverted in a Previous Gilead-Sponsored Study of ADV.

> **NCT00158717** · — · COMPLETED · sponsor: **Gilead Sciences** · enrollment: 107 (actual)

## Conditions studied

- Hepatitis B

## Interventions

- **DRUG:** Hepsera

## Key facts

- **NCT ID:** NCT00158717
- **Lead sponsor:** Gilead Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2003-04
- **Primary completion:** 2006-04
- **Final completion:** 2006-04
- **Target enrollment:** 107 (ACTUAL)
- **Last updated:** 2014-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00158717

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00158717, "Observational Study of the Durability of Seroconversion Chronic HBV Patients Who Seroconverted in a Previous Gilead-Sponsored Study of ADV.". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00158717. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*